Beginning in mid-February 2008, the 1997-2007 online version of the Science Watch® newsletter, ESI-Topics.com, and in-cites.com, will all be featured together on the redesigned ScienceWatch.com. All previous content from the three sites will be permanently archived, and remain accessible from any existing bookmarks to the archived pages. No new content will be added to this site. Updates and new content (updated biweekly) are available at ScienceWatch.com now.

New Hot Paper Comments

By Jürgen Bajorath

ESI Special Topics, March 2006
Citing URL - http://www.esi-topics.com/nhp/2006/march-06-JurgenBajorath.html

Jürgen Bajorath answers a few questions about this month's new hot paper in the field of Pharmacology & Toxicology.


From •>>March 2006

Field: Pharmacology & Toxicology
Article Title: Docking and scoring in virtual screening for drug discovery: Methods and applications
Authors: Kitchen, DB;Decornez, H;Furr, JR;Bajorath, J
Journal: NAT REV DRUG DISCOV
Volume: 3
Issue: 11
Page: 935-949
Year: NOV 2004
* AMRI BRC, 18804 N Creek Parkway, Bothell, WA 98011 USA.
* AMRI BRC, Bothell, WA 98011 USA.
* AMRI, Dept Comp Aided Drug Discovery, Albany, NY 12212 USA.
* Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA.

ST:  Why do you think your paper is highly cited?


“The paper presents a rather critical review of computational methods for structure-based ligand design and virtual screening...”

The paper presents a rather critical review of computational methods for structure-based ligand design and virtual screening with a strong focus on drug discovery problems. It covers both the hit identification and lead optimization stages, which sets it apart from a number of other reviews.

ST:  Does it describe a new discovery or a new methodology that’s useful to others?

Docking methods are widely used in basic and applied pharmaceutical research and many different algorithms and scoring schemes have been introduced. However, successful applications do generally require a fairly high level of expertise and experience. I believe what this review helps achieve is a focusing on promising application scenarios while avoiding some principal caveats.

ST:  Could you summarize the significance of your paper in layman's terms?

It describes many different methods for the structure-based discovery of new active compounds and discusses exemplary applications in case studies. Importantly, it attempts to illustrate the pros and cons of various approaches.

ST:  How did you become involved in this research, and were any problems encountered along the way?

Considering 3D protein structure information in the context of drug design and discovery immediately leads to an interest in docking methods. This is also where my interest in this area of research originated. However, finding new hits or leads via docking is far from being a routine process. We have succeeded in some cases and failed in others.End

Prof. Jürgen Bajorath
Chair of Life Science Informatics
B-IT Intl. Center for Information Technology 
Rheinische Friedrich-Wilhelms-University Bonn 
Bonn, Germany

ESI Special Topics, March 2006
Citing URL - http://www.esi-topics.com/nhp/2006/march-06-JurgenBajorath.html

•> Search Special Topics
New Hot Papers Menu || All Topics Menu
New Hot Papers Comments Menu
Help || About || Contact

ScienceWatch.com - Tracking Trends and Perfomance in Basic Research
Go to the new ScienceWatch.com

Write to the Webmaster with questions/comments. Terms of Usage.
The Research Services Group of Thomson Scientific |
(c) 2008 The Thomson Corporation.